A Form 4 filed on September 1, 2026 reported that Karen Marie Rapp, a director of Plexus Corp (NASDAQ:PLXS), sold 500 shares of common stock on August 31, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Karen Marie Rapp, identified as a Director of Plexus Corp.
  • Transaction: 500 shares of Common Stock, $0.01 par value, disposed of (sold) on August 31, 2026.
  • Sale price: $240.87 per share.
  • Remaining ownership: 7,535 shares of common stock beneficially owned directly following the transaction.
  • Plan basis: Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 6, 2026.
  • Filing form: Signed by Kate A. Gitter as Attorney-in-Fact for Karen Rapp, and dated September 1, 2026.

Plexus Corp Director Karen Rapp Reports Share Sale Under Pre-Arranged Plan

According to the Form 4 filing, Karen Marie Rapp, a director of Plexus Corp, disposed of 500 shares of Plexus Corp Common Stock, $0.01 par value, on August 31, 2026. The transaction was coded "S," indicating a sale, at a price of $240.87 per share. The filing notes the transaction was direct, with Rapp holding the shares in her own name.

The filing discloses that the sale was executed "pursuant to a Rule 10b5-1 plan adopted on February 6, 2026," meaning the transaction was carried out under a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The Form 4 includes a checkmark indicating this, as noted in the filing's header. Following the reported transaction, Rapp directly holds 7,535 shares of Plexus Corp common stock, according to the filing.

No derivative securities transactions were reported in Table II of this filing. The form was filed by one reporting person and was signed by Kate A. Gitter as Attorney-in-Fact on September 1, 2026. Plexus Corp is listed on NASDAQ under the ticker PLXS, with its principal address listed as One Plexus Way, Neenah, Wisconsin 54956.

What Was Disclosed

The filing reports a single sale of 500 Plexus Corp common shares by director Karen Marie Rapp on August 31, 2026, at $240.87 per share, executed under a pre-established Rule 10b5-1 plan. Rapp retained direct beneficial ownership of 7,535 shares after the transaction.